Literature DB >> 2431373

Spindle-cell squamous carcinoma of head and neck region: a clinicopathologic and immunohistochemical study of eight cases.

E Leonardi, P Dalri, T Pusiol, R Valdagni, F Piscioli.   

Abstract

Spindle cell squamous carcinoma is a highly malignant neoplasm, characterized by a biphasic appearance, due to the presence of a diffuse proliferative pattern of pleomorphic spindle cells with extremely rare foci of conventional squamous cell carcinoma. Epithelial markers in eight cases of spindle-cell squamous carcinoma of the head and neck region were studied by immunocytochemistry. Epithelial membrane antigen and cytokeratin resulted strongly positive in the spindle cells of the sarcoma-like areas demonstrating the epithelial nature of the neoplasm. In 6 of our patients who later died from widespread metastases, the neoplasm had poor prognosis with a mean survival rate of 14.7 months.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431373     DOI: 10.1159/000275882

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  3 in total

1.  Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis.

Authors:  Ruchika Gupta; Sompal Singh; Suresh Hedau; Sonu Nigam; Bhudev C Das; Ishwar Singh; Ashish Kumar Mandal
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

2.  A case of oral multiple primary cancer including Spindle Cell Carcinoma.

Authors:  Hideharu Kato; Jouji Nomura; Yoshihiko Matsumura; Shigeaki Yanase; Kaori Miyahara; Rina Matsuura; Toshiro Tagawa
Journal:  J Maxillofac Oral Surg       Date:  2010-09-22

3.  Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma.

Authors:  Carlos N Prieto-Granada; Bin Xu; Bayan Alzumaili; Mohamed Rizwan Haroon Al Rasheed; Antoine Eskander; Danny Enepekides; Snehal G Patel; Todd M Stevens; Snjezana Dogan; Ronald Ghossein; Nora Katabi
Journal:  Virchows Arch       Date:  2021-05-12       Impact factor: 4.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.